Controllability analysis of protein glycosylation in Cho cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  St Amand, Melissa M ^a   Tran, Kevin ^a   Radhakrishnan, Devesh ^a   Robinson, Anne S ^a,b   Ogunnaike, Babatunde A ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN;

ARTICLE; CHO CELL; ENDOPLASMIC RETICULUM; GENETIC ENGINEERING; GOLGI COMPLEX; METHODOLOGY; NONLINEAR SYSTEM; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; SIMULATION;

ANIMALS; CHO CELLS; COMPUTER SIMULATION; CRICETINAE; CRICETULUS; GLYCOPROTEINS; GLYCOSYLATION; MODELS, THEORETICAL; POLYSACCHARIDES;

EID: 84894639207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087973     Document Type: Article

References (33)

1. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, et al. (2011) The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nature Biotechnology 29: 735-U131.
2. Hossler P, Khattak SF, Li ZJ (2009) Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19: 936-949.
3. Goochee CF, Gramer MJ, Andersen DC, Bahr JB, Rasmussen JR (1991) The Oligosaccharides of Glycoproteins - Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties. Bio-Technology 9: 1347-1355.
4. Butler M (2006) Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Cytotechnology 50: 57-76.
5. Geyer H, Geyer R (2006) Strategies for analysis of glycoprotein glycosylation. Biochimica Et Biophysica Acta-Proteins and Proteomics 1764: 1853-1869. (Pubitemid 44895032)
6. Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, et al. (2008) Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins. Current Pharmaceutical Biotechnology 9: 482-501.
7. Raju TS (2008) Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Current Opinion in Immunology 20: 471-478.
8. FDA (2009) Q8(R1) Pharmaceutical Development Revision 1. In: CDER C, editor. Rockiville, MD.
9. Ray WH (1981) Advanced Process Control: McGraw-Hill Book Company. 376 p.
10. Morari M (1983) Design of Resilient Processing Plants. 3. A General Framework for the Assessment of Dynamic Resilience. Chemical Engineering Science 38: 1881-1891.
11. Zhao Y, Skogestad S (1997) Comparison of various control configurations for continuous bioreactors. Industrial & Engineering Chemistry Research 36: 697-705. (Pubitemid 127493383)
12. Lewin DR, Bogle D (1996) Controllability analysis of an industrial polymerization reactor. Computers & Chemical Engineering 20: S871-S876. (Pubitemid 126653505)
13. Kaymak DB, Luyben WL (2008) Quantitative comparison of dynamic controllability between a reactive distillation column and a conventional multi-unit process. Computers & Chemical Engineering 32: 1456-1470. (Pubitemid 351608418)
14. Garcia VM, Lopez E, Serra M, Llorca J, Riera J (2010) Dynamic modeling and controllability analysis of an ethanol reformer for fuel cell application. International Journal of Hydrogen Energy 35: 9768-9775.
15. Umana P, Bailey JE (1997) A mathematical model of N-linked glycoform biosynthesis. Biotechnology and Bioengineering 55: 890-908. (Pubitemid 27360509)
16. Krambeck FJ, Betenbaugh MJ (2005) A mathematical model of N-linked glycosylation. Biotechnology and Bioengineering 92: 711-728. (Pubitemid 41772467)
17. Kontoravdi C, Asprey SP, Pistikopoulos EN, Mantalaris A (2007) Development of a dynamic model of monoclonal antibody production and glycosylation for product quality monitoring; 2007. pp. 392-400.
18. Hossler P, Mulukutla BC, Hu WS (2007) Systems Analysis of N-Glycan Processing in Mammalian Cells. Plos One 2.
19. del Val IJ, Nagy JM, Kontoravdi C (2011) A dynamic mathematical model for monoclonal antibody N-linked glycosylation and nucleotide sugar donor transport within a maturing Golgi apparatus. Biotechnology Progress 27: 1730-1743.
20. Vinson DR, Georgakis C (2000) A new measure of process output controllability. Journal of Process Control 10: 185-194. (Pubitemid 30556716)
21. Ogunnaike BA (2009) Random Phenomena: Fundamentals of Probability and Statistics for Engineers. Boca RatonFL: Taylor & Francis Group. 789-845 p.
22. Montgomery DC (2009) Design and Analysis of Experiments. 7 ed. Hoboken, NJ: John Wiley & Sons, Inc.
23. Lay DC (2006) Linear Algebra and its Applications. 3rd ed. Rockville, MD: Pearson Addison Wesley. pp. 471-481.
24. Box GEP, Hunter WG, Hunter JS (1978) Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. USA: John Wiley & Sons, Inc.
25. St.Amand MM, Radhakrishnan D, Robinson AS, Ogunnaike BA (in preparation) Identification of manipulated variables for a glycosylation control strategy.
26. St. Amand MM, Hayes J, Radhakrishnan D, Fernandez J, Meyer W, et alin preparation) Identifying a robust design space for glycosylation during monoclonal antibody production.
27. Ferrara C, Brunker P, Suter T, Moser S, Puntener U, et al. (2006) Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co-expression of heterologous beta 1,4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Biotechnology and Bioengineering 93: 851-861.
28. Sburlati AR, Umana P, Prati EGP, Bailey JE (1998) Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglu- cosaminyltransferase III in Chinese hamster ovary cells. Biotechnology Progress 14: 189-192. (Pubitemid 28202601)
29. Umana P, Jean-Mairet J, Bailey JE (1999) Tetracycline-regulated overexpression of glycosyltransferases in Chinese hamster ovary cells. Biotechnology and Bioengineering 65: 542-549. (Pubitemid 29513646)
30. Satoh M, Iida S, Shitara K (2006) Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opinion on Biological Therapy 6: 1161-1173. (Pubitemid 44714143)
31. Chen PF, Harcum SW (2006) Effects of elevated ammonium on glycosylation gene expression in CHO cells. Metabolic Engineering 8: 123-132.
32. Wong DCF, Wong NSC, Goh JSY, May LM, Yap MGS (2010) Profiling of N-Glycosylation Gene Expression in CHO Cell Fed-Batch Cultures. Biotechnology and Bioengineering 107: 516-528.
33. Wong NSC, Wati L, Nissom PM, Feng HT, Lee MM, et al. (2010) An Investigation of Intracellular Glycosylation Activities in CHO Cells: Effects of Nucleotide Sugar Precursor Feeding. Biotechnology and Bioengineering 107: 321-336.